EP3283060A4 - Bolaamphiphilic compounds, compositions and uses thereof - Google Patents

Bolaamphiphilic compounds, compositions and uses thereof Download PDF

Info

Publication number
EP3283060A4
EP3283060A4 EP16780822.9A EP16780822A EP3283060A4 EP 3283060 A4 EP3283060 A4 EP 3283060A4 EP 16780822 A EP16780822 A EP 16780822A EP 3283060 A4 EP3283060 A4 EP 3283060A4
Authority
EP
European Patent Office
Prior art keywords
compositions
bolaamphiphilic compounds
bolaamphiphilic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP16780822.9A
Other languages
German (de)
French (fr)
Other versions
EP3283060A1 (en
Inventor
Charles Linder
Eliahu Heldman
Sarina Grinberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lauren Sciences LLC
Original Assignee
Lauren Sciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lauren Sciences LLC filed Critical Lauren Sciences LLC
Publication of EP3283060A1 publication Critical patent/EP3283060A1/en
Publication of EP3283060A4 publication Critical patent/EP3283060A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP16780822.9A 2015-04-16 2016-04-15 Bolaamphiphilic compounds, compositions and uses thereof Pending EP3283060A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562148511P 2015-04-16 2015-04-16
US201562258773P 2015-11-23 2015-11-23
PCT/US2016/027726 WO2016168580A1 (en) 2015-04-16 2016-04-15 Bolaamphiphilic compounds, compositions and uses thereof

Publications (2)

Publication Number Publication Date
EP3283060A1 EP3283060A1 (en) 2018-02-21
EP3283060A4 true EP3283060A4 (en) 2018-12-19

Family

ID=57126121

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16780822.9A Pending EP3283060A4 (en) 2015-04-16 2016-04-15 Bolaamphiphilic compounds, compositions and uses thereof

Country Status (5)

Country Link
EP (1) EP3283060A4 (en)
AU (1) AU2016248992A1 (en)
CA (1) CA3018945A1 (en)
IL (1) IL255042B (en)
WO (1) WO2016168580A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022087175A1 (en) * 2020-10-21 2022-04-28 University Of San Diego Multivalent terpene-based bolaamphiphiles for gene delivery
IL302607A (en) * 2020-11-03 2023-07-01 Onconano Medicine Inc Therapeutic ph responsive compositions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014039504A1 (en) * 2012-09-04 2014-03-13 Lauren Sciences Llc Bolaamphiphilic compounds, compositions and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9642803B2 (en) * 2009-05-04 2017-05-09 Ben-Gurion University Of The Negev Research And Development Authority Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery
AU2013312909C1 (en) * 2012-09-04 2018-02-08 Lauren Sciences Llc Bolaamphiphilic compounds, compositions and uses thereof
WO2014039501A1 (en) * 2012-09-04 2014-03-13 Lauren Sciences Llc Bolaamphiphilic compounds, compositions and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014039504A1 (en) * 2012-09-04 2014-03-13 Lauren Sciences Llc Bolaamphiphilic compounds, compositions and uses thereof

Also Published As

Publication number Publication date
IL255042B (en) 2022-04-01
AU2016248992A1 (en) 2017-12-07
CA3018945A1 (en) 2016-10-20
IL255042A0 (en) 2017-12-31
EP3283060A1 (en) 2018-02-21
WO2016168580A1 (en) 2016-10-20

Similar Documents

Publication Publication Date Title
EP3665156A4 (en) Compounds, compositions and methods
PL3407888T3 (en) Pyridopyrroloquinoxaline compounds, their compositions and uses
EP3676297A4 (en) Compounds, compositions and methods
EP3240555A4 (en) Multi-supplement compositions
EP3398996A4 (en) Composition
EP3339331A4 (en) Composition
AU2016291708B2 (en) Plinabulin compositions
EP3157515A4 (en) Platinum compounds, compositions, and uses thereof
EP3494119A4 (en) Compounds and compositions and uses thereof
EP3248475A4 (en) Composition
EP3268368A4 (en) Aza-pyridone compounds and uses thereof
EP3552017A4 (en) Compounds, compositions and methods
EP3322411A4 (en) Flourinated cbd compounds, compositions and uses thereof
EP3480228A4 (en) Composition
EP3313393A4 (en) Platinum compounds, compositions, and uses thereof
EP3316871A4 (en) Talc-bound compositions and uses thereof
EP3288386A4 (en) Anti-phytopathogenic compositions
EP3556804A4 (en) Composition
EP3478296A4 (en) Phosopholipid compositions
EP3369418A4 (en) Composition
EP3349766A4 (en) Anti-hemorrhaging compositions
EP3490607A4 (en) Compounds and compositions and uses thereof
EP3366730A4 (en) Water-based-ink composition
EP3299025A4 (en) Composition, containingquisaqualis indica
IL261782A (en) Carbapenem compounds, compositions comprising same and uses thereof

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20171116

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20181120

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 47/26 20060101ALI20181114BHEP

Ipc: A61K 9/107 20060101AFI20181114BHEP

Ipc: A61K 47/18 20170101ALI20181114BHEP

Ipc: A61P 25/28 20060101ALI20181114BHEP

Ipc: A61K 38/00 20060101ALI20181114BHEP

Ipc: A61K 9/127 20060101ALI20181114BHEP

Ipc: A61K 9/00 20060101ALI20181114BHEP

Ipc: A61K 9/51 20060101ALI20181114BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20201111

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS